Table 2.
Condition | Repeatability parameter | |||||
---|---|---|---|---|---|---|
|
|
|||||
MRE method |
Breath-hold phase |
Driver type |
Bias (kPa) |
RC | LOA (kPa) |
ICC |
2D* | Expiration | Rigid | 0.07 | 0.29 | −0.22, 0.36 | 0.86 (0.56, 0.96) |
2D | Expiration | Flexible | 0.01 | 0.33 | −0.32, 0.34 | 0.91 (0.70, 0.98) |
2D | Inspiration | Rigid | 0.05 | 0.49 | −0.44, 0.55 | 0.71 (0.22, 0.92) |
2D | Inspiration | Flexible | −0.05 | 0.36 | −0.41, 0.31 | 0.88 (0.61, 0.97) |
3D | Expiration | Rigid | −0.02 | 0.20 | −0.22, 0.19 | 0.84 (0.49, 0.96) |
3D | Expiration | Flexible | 0.01 | 0.20 | −0.19, 0.21 | 0.90 (0.65, 0.97) |
3D | Inspiration | Rigid | 0.01 | 0.16 | −0.16, 0.17 | 0.96 (0.86, 0.99) |
3D | Inspiration | Flexible | 0.03 | 0.26 | −0.22, 0.29 | 0.90 (0.65, 0.97) |
RC = Repeatability coefficient; LOA = limit of agreement; ICC = Intraclass coefficient of repeatability; ROI = Regions of Interests.
Values in parentheses are 95% confidence limits.
This implementation of MRE is the FDA-approved clinically available implementation of MRE.